Yiyao Xu
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 20
- Health Informatics top 5%
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 9
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis 9
- Pancreatic and Hepatic Oncology Research 7
- Cancer Immunotherapy and Biomarkers 7
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 17
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 26
-
- Gallbladder and Bile Duct Disorders 7
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Yiyao Xu
81 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Hepatology 286
- Health Informatics 38
- Cancer Research 246
- Oncology 422
- Epidemiology 325
Countries citing papers authored by Yiyao Xu
This map shows the geographic impact of Yiyao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiyao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiyao Xu more than expected).
Fields of papers citing papers by Yiyao Xu
This network shows the impact of papers produced by Yiyao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiyao Xu. The network helps show where Yiyao Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yiyao Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 5 | |
| 4 | Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysisbreakdown → | 2023 | 92 |
| 5 | 2023 | 3 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 2 | |
| 9 | 2021 | 7 | |
| 10 | 2020 | 1 | |
| 11 | 2020 | 23 | |
| 12 | 2020 | 21 | |
| 13 | 2019 | 8 | |
| 14 | 2017 | 23 | |
| 15 | 2017 | 3 | |
| 16 | 2016 | 14 | |
| 17 | 2016 | 1 | |
| 18 | 2012 | 35 | |
| 19 | 2010 | 2 | |
| 20 | 2010 | 4 |
About Yiyao Xu
Yiyao Xu is a scholar working on Hepatology, Cancer Research and Oncology, having authored 88 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (26 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Liver Disease Diagnosis and Treatment (17 papers), Cancer, Lipids, and Metabolism (9 papers), Inflammatory Biomarkers in Disease Prognosis (9 papers), Pancreatic and Hepatic Oncology Research (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Gallbladder and Bile Duct Disorders (7 papers). The work is most often cited by research in Hepatology (286 citations), Health Informatics (38 citations) and Cancer Research (246 citations). Yiyao Xu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Xinting Sang, Haitao Zhao, Xin Lu, Xin Lü, Shitao Jiang, Huayu Yang, Shunda Du, Yilei Mao, Shouxian Zhong and Hanchun Huang. Their work appears in journals such as Biomaterials, Gut and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.